342 related articles for article (PubMed ID: 35972717)
1. Orexin Receptor Antagonists and Insomnia.
Wu X; Xue T; Chen Z; Wang Z; Chen G
Curr Psychiatry Rep; 2022 Oct; 24(10):509-521. PubMed ID: 35972717
[TBL] [Abstract][Full Text] [Related]
2. Orexin Receptor Antagonists in the Treatment of Depression: A Leading Article Summarising Pre-clinical and Clinical Studies.
Fagan H; Jones E; Baldwin DS
CNS Drugs; 2023 Jan; 37(1):1-12. PubMed ID: 36436175
[TBL] [Abstract][Full Text] [Related]
3. Clinical pharmacology, efficacy, and safety of orexin receptor antagonists for the treatment of insomnia disorders.
Muehlan C; Vaillant C; Zenklusen I; Kraehenbuehl S; Dingemanse J
Expert Opin Drug Metab Toxicol; 2020 Nov; 16(11):1063-1078. PubMed ID: 32901578
[TBL] [Abstract][Full Text] [Related]
4. Orexin Receptor Antagonism: Normalizing Sleep Architecture in Old Age and Disease.
Kron JOJ; Keenan RJ; Hoyer D; Jacobson LH
Annu Rev Pharmacol Toxicol; 2024 Jan; 64():359-386. PubMed ID: 37708433
[TBL] [Abstract][Full Text] [Related]
5. Dual orexin receptor antagonists increase sleep and cataplexy in wild type mice.
Mahoney CE; Mochizuki T; Scammell TE
Sleep; 2020 Jun; 43(6):. PubMed ID: 31830270
[TBL] [Abstract][Full Text] [Related]
6. Evidence-based insomnia treatment strategy using novel orexin antagonists: A review.
Kishi T; Nishida M; Koebis M; Taninaga T; Muramoto K; Kubota N; Moline M; Sakuma K; Okuya M; Nomura I; Iwata N
Neuropsychopharmacol Rep; 2021 Dec; 41(4):450-458. PubMed ID: 34553844
[TBL] [Abstract][Full Text] [Related]
7. An Update on Dual Orexin Receptor Antagonists and Their Potential Role in Insomnia Therapeutics.
Janto K; Prichard JR; Pusalavidyasagar S
J Clin Sleep Med; 2018 Aug; 14(8):1399-1408. PubMed ID: 30092886
[TBL] [Abstract][Full Text] [Related]
8. A Comprehensive Review of Daridorexant, a Dual-Orexin Receptor Antagonist as New Approach for the Treatment of Insomnia.
Ziemichód W; Grabowska K; Kurowska A; Biała G
Molecules; 2022 Sep; 27(18):. PubMed ID: 36144776
[TBL] [Abstract][Full Text] [Related]
9. Orexin in sleep, addiction and more: is the perfect insomnia drug at hand?
Hoyer D; Jacobson LH
Neuropeptides; 2013 Dec; 47(6):477-88. PubMed ID: 24215799
[TBL] [Abstract][Full Text] [Related]
10. Preclinical in vivo characterization of lemborexant (E2006), a novel dual orexin receptor antagonist for sleep/wake regulation.
Beuckmann CT; Ueno T; Nakagawa M; Suzuki M; Akasofu S
Sleep; 2019 Jun; 42(6):. PubMed ID: 30923834
[TBL] [Abstract][Full Text] [Related]
11. The orexin story and orexin receptor antagonists for the treatment of insomnia.
Muehlan C; Roch C; Vaillant C; Dingemanse J
J Sleep Res; 2023 Dec; 32(6):e13902. PubMed ID: 37086045
[TBL] [Abstract][Full Text] [Related]
12. Orexin Receptor Antagonists: New Therapeutic Agents for the Treatment of Insomnia.
Roecker AJ; Cox CD; Coleman PJ
J Med Chem; 2016 Jan; 59(2):504-30. PubMed ID: 26317591
[TBL] [Abstract][Full Text] [Related]
13. Orexin Receptor Antagonists as Adjunct Drugs for the Treatment of Depression: A Mini Meta-Analysis.
Uğurlu M
Noro Psikiyatr Ars; 2024; 61(1):77-84. PubMed ID: 38496221
[TBL] [Abstract][Full Text] [Related]
14. [Preclinical and clinical efficacy of orexin receptor antagonist Lemborexant (Dayvigo
Koebisu M; Koyama N; Nishida M; Muramoto K
Nihon Yakurigaku Zasshi; 2021; 156(2):114-119. PubMed ID: 33642529
[TBL] [Abstract][Full Text] [Related]
15. Discovery and development of orexin receptor antagonists as therapeutics for insomnia.
Winrow CJ; Renger JJ
Br J Pharmacol; 2014 Jan; 171(2):283-93. PubMed ID: 23731216
[TBL] [Abstract][Full Text] [Related]
16. Orexin, Sleep, Sympathetic Neural Activity, and Cardiovascular Function.
Bigalke JA; Shan Z; Carter JR
Hypertension; 2022 Dec; 79(12):2643-2655. PubMed ID: 36148653
[TBL] [Abstract][Full Text] [Related]
17. Clinical usefulness of dual orexin receptor antagonism beyond insomnia: Neurological and psychiatric comorbidities.
Carpi M; Palagini L; Fernandes M; Calvello C; Geoffroy PA; Miniati M; Pini S; Gemignani A; Mercuri NB; Liguori C
Neuropharmacology; 2024 Mar; 245():109815. PubMed ID: 38114045
[TBL] [Abstract][Full Text] [Related]
18. Nonclinical pharmacology of daridorexant: a new dual orexin receptor antagonist for the treatment of insomnia.
Roch C; Bergamini G; Steiner MA; Clozel M
Psychopharmacology (Berl); 2021 Oct; 238(10):2693-2708. PubMed ID: 34415378
[TBL] [Abstract][Full Text] [Related]
19. The Quest for the Best Dual Orexin Receptor Antagonist (Daridorexant) for the Treatment of Insomnia Disorders.
Boss C; Gatfield J; Brotschi C; Heidmann B; Sifferlen T; von Raumer M; Schmidt G; Williams JT; Treiber A; Roch C
ChemMedChem; 2020 Dec; 15(23):2286-2305. PubMed ID: 32937014
[TBL] [Abstract][Full Text] [Related]
20. Daridorexant for the treatment of insomnia disorder: findings and implications.
Dos Santos JBR; da Silva MRR
Eur J Clin Pharmacol; 2022 Nov; 78(11):1749-1761. PubMed ID: 36098753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]